Many people with lupus experience problems with their heart, lungs, and blood . Lupus increases your risk of cardiovascular disease or “heart disease”, which is a leading cause of death among patients ...

The Michael Jon Barlin Pediatric Lupus Research program provides funding for research projects that have the potential to significantly advance the field of or impact the lives of children living with ...

UCB and Biogen's lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus standard care.

BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory systemic lupus erythematosus (SLE) get symptoms under control ...

Monitoring blood hydroxychloroquine levels could help to ensure that patients with SLE are being treated with the drug optimally, study findings suggest.

Merck KGaA has shed light on the failure in one lupus cohort, while pointing to secondary endpoint wins as proof that enpatoran still deserves a shot.

The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.

Investigators identified factors associated with sustained complete renal response in lupus nephritis. Achieving sustained complete renal response is feasible in patients with lupus nephritis.

Find the latest Lupus news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.

FDA starts a review of Roche's Gazyva as a treatment for lupus nephritis, an indication that analysts think could unlock renewed sales growth.

Managing a chronic condition like lupus can be stressful. Here’s what to know about the risk of mood disorders and how to manage mental health.